Countries South Korea

Celltrion Celebrates a Decade of Biosimilar Innovation in Europe

Marking 10 years since the European Medicines Agency (EMA) approved the world’s first monoclonal antibody biosimilar infliximab, for all indication...

 September 11, 2023 | News

Seegene Launches 'Open Innovation Program' with Springer Nature

The 'Open Innovation Program' is a part of the Seegene OneSystemTM business aimed at creating a world free from all diseases - through development of ...

 September 05, 2023 | News

South Korea's Genexine's Long-Acting Growth Hormone Meets Phase 3 Endpoint

Phase 3 clinical trial in China meets primary endpoint On track to file BLA in China in 2024 The study being conducted by Genexine’s partner in...

 August 31, 2023 | News

GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

Under the MOU, both parties agreed to cooperate for a successful supply of the vaccine. While Eubiologics, a developer and producer of Euvichol, takes char...

 August 28, 2023 | News

SK Bioscience and Vaxxas Partner for Needle-Free Typhoid Vaccine Patch

SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collaboration is set to revolutionize vaccine delivery by devel...

 August 24, 2023 | News

Samsung Biologics appoints new leadership to oversee quality and regulatory affairs

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced the appointments of Gail Ward...

 August 24, 2023 | News

MGI Partners with NGeneBio to Advance Precision Medicine

This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceler...

 August 23, 2023 | News

CanariaBio's MAb-AR20.5 for Pancreatic Cancer Granted FDA Orphan Drug Designation

CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immunotherapies for cancer, anno...

 August 22, 2023 | News

Surging demand for Korean pharma in 2023 ahead of CPHI Korea

In exciting news for the Korean pharma, the industry in Korea has seen its ‘growth potential’ increase by 7% in the 2023 CPHI Annual Survey[1]....

 August 11, 2023 | News

Standigm and Nashville Biosciences join to revolutionize early drug discovery

 Standigm, a company using artificial intelligence (AI) technology for drug discovery and development,  announced that it is collaborating with N...

 August 11, 2023 | News

Positive Phase 3 Results for Fasedienol Nasal Spray in Social Anxiety Disorder by AffaMed's Partner Vistagen

First positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years Statistically significant rapid-onset reducti...

 August 11, 2023 | News

SK bioscience Announces Equity Investment in Novavax to Strengthen Strategic Partnership

SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation and strengthen their strategic partnership. SK bioscien...

 August 09, 2023 | News

Certara Teams Up with Korea Institute of Toxicology for FDA-Ready SEND Dataset

Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certar...

 August 04, 2023 | News

Daewoong Pharmaceutical Seeks Approval for Fexuprazan in China's Anti-Ulcer Drug Market

Daewoong Pharmaceutical's domestically produced drug no. 34 Fexuprazan, a newly developed one for the treatment of gastroesophageal reflux disease (GERD), ...

 July 31, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close